USA |NASDAQ |USD
|Public Float||1.83M||P/E Ratio||-|
|% Short of Float||-||Dividend (Yield)||-|
|Held by Insiders||14.92%||Ex-Dividend Date|
|Held by Institutions||26.17%||IPO Date||Jun 27, 2014|
|Dec 20||Dec 19||Dec 18|
|Jun 21||Mar 21||Dec 20|
|Jan 21, 2022||$4.67||$4.67||$3.70||$3.70||-19.74%||85.40K|
Helius medical technologies is expected to report earnings on May 16 ,2022.
View More Details on Helius medical technologies's 'Earnings' Section
Helius medical technologies trades on the NASDAQ stock market in USA under the ticker symbol "HSDT". Helius medical technologies’s stock symbol can also be displayed as "NASDAQ:HSDT".
Helius medical technologies (NASDAQ:HSDT) is owned by 26.17% institutional shareholders and by 14.92% insiders. The rest is owned by the public.
The 3 top institutional shareholders are "AIGH Capital Management, LLC", "Vanguard Group Inc" and "ACT Capital Management, LLC", representing 10.32% of Helius medical technologies’s total shares outstanding.
Explore More Details on Helius medical technologies's “Ownership” Section
Helius medical technologies's key executive team includes the following managers:
Helius medical technologies (NASDAQ:HSDT) is classified under the "Healthcare" sector and under the "Medical Devices" industry.
Currently the number of employees working for Helius medical technologies is 19.
Helius medical technologies (NASDAQ:HSDT) is headquartered in PA, United States.
Helius medical technologies’s mailing address is 642 Newtown Yardley Road, Newtown, PA, United States, 18940.
The company’s phone number is 215 944 6100.